These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 17616997)

  • 1. Drug-herb interaction: effect of St John's wort on bioavailability and metabolism of procainamide in mice.
    Dasgupta A; Hovanetz M; Olsen M; Wells A; Actor JK
    Arch Pathol Lab Med; 2007 Jul; 131(7):1094-8. PubMed ID: 17616997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. St. John's wort does not interfere with therapeutic drug monitoring of 12 commonly monitored drugs using immunoassays.
    Dasgupta A; Tso G; Szelei-Stevens K
    J Clin Lab Anal; 2006; 20(2):62-7. PubMed ID: 16538644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of St. John's wort supplementation on ibuprofen pharmacokinetics.
    Bell EC; Ravis WR; Lloyd KB; Stokes TJ
    Ann Pharmacother; 2007 Feb; 41(2):229-34. PubMed ID: 17284505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of St John's wort (Hypericum perforatum) on human cytochrome P450 activity.
    Wang Z; Gorski JC; Hamman MA; Huang SM; Lesko LJ; Hall SD
    Clin Pharmacol Ther; 2001 Oct; 70(4):317-26. PubMed ID: 11673747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of St John's wort on imatinib mesylate pharmacokinetics.
    Frye RF; Fitzgerald SM; Lagattuta TF; Hruska MW; Egorin MJ
    Clin Pharmacol Ther; 2004 Oct; 76(4):323-9. PubMed ID: 15470331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional induction and de-induction of P-glycoprotein by St. John's wort and its ingredients in a human colon adenocarcinoma cell line.
    Tian R; Koyabu N; Morimoto S; Shoyama Y; Ohtani H; Sawada Y
    Drug Metab Dispos; 2005 Apr; 33(4):547-54. PubMed ID: 15640377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of St John's wort on drug metabolism by induction of cytochrome P450 3A4 enzyme.
    Markowitz JS; Donovan JL; DeVane CL; Taylor RM; Ruan Y; Wang JS; Chavin KD
    JAMA; 2003 Sep; 290(11):1500-4. PubMed ID: 13129991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The interaction between St John's wort and an oral contraceptive.
    Hall SD; Wang Z; Huang SM; Hamman MA; Vasavada N; Adigun AQ; Hilligoss JK; Miller M; Gorski JC
    Clin Pharmacol Ther; 2003 Dec; 74(6):525-35. PubMed ID: 14663455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic interactions of drugs with St John's wort.
    Zhou S; Chan E; Pan SQ; Huang M; Lee EJ
    J Psychopharmacol; 2004 Jun; 18(2):262-76. PubMed ID: 15260917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The emerging recognition of herb-drug interactions with a focus on St. John's wort (Hypericum perforatum).
    Markowitz JS; DeVane CL
    Psychopharmacol Bull; 2001; 35(1):53-64. PubMed ID: 12397870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding drug interactions with St John's wort (Hypericum perforatum L.): impact of hyperforin content.
    Chrubasik-Hausmann S; Vlachojannis J; McLachlan AJ
    J Pharm Pharmacol; 2019 Jan; 71(1):129-138. PubMed ID: 29411879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative characterization of direct P-glycoprotein inhibition by St John's wort constituents hypericin and hyperforin.
    Wang EJ; Barecki-Roach M; Johnson WW
    J Pharm Pharmacol; 2004 Jan; 56(1):123-8. PubMed ID: 14980009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of St John's wort and CYP2C9 genotype on the pharmacokinetics and pharmacodynamics of gliclazide.
    Xu H; Williams KM; Liauw WS; Murray M; Day RO; McLachlan AJ
    Br J Pharmacol; 2008 Apr; 153(7):1579-86. PubMed ID: 18204476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of St. John's Wort on Intravenous Fentanyl Pharmacokinetics, Pharmacodynamics, and Clinical Effects: A Randomized Clinical Trial.
    Loughren MJ; Kharasch ED; Kelton-Rehkopf MC; Syrjala KL; Shen DD
    Anesthesiology; 2020 Mar; 132(3):491-503. PubMed ID: 31794512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The recovery time-course of CYP3A after induction by St John's wort administration.
    Imai H; Kotegawa T; Tsutsumi K; Morimoto T; Eshima N; Nakano S; Ohashi K
    Br J Clin Pharmacol; 2008 May; 65(5):701-7. PubMed ID: 18294328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. St John's wort induces both cytochrome P450 3A4-catalyzed sulfoxidation and 2C19-dependent hydroxylation of omeprazole.
    Wang LS; Zhou G; Zhu B; Wu J; Wang JG; Abd El-Aty AM; Li T; Liu J; Yang TL; Wang D; Zhong XY; Zhou HH
    Clin Pharmacol Ther; 2004 Mar; 75(3):191-7. PubMed ID: 15001970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different effects of St John's wort on the pharmacokinetics of simvastatin and pravastatin.
    Sugimoto K; Ohmori M; Tsuruoka S; Nishiki K; Kawaguchi A; Harada K; Arakawa M; Sakamoto K; Masada M; Miyamori I; Fujimura A
    Clin Pharmacol Ther; 2001 Dec; 70(6):518-24. PubMed ID: 11753267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of St. John's wort supplementation on the pharmacokinetics of bupropion in healthy male Chinese volunteers.
    Lei HP; Yu XY; Xie HT; Li HH; Fan L; Dai LL; Chen Y; Zhou HH
    Xenobiotica; 2010 Apr; 40(4):275-81. PubMed ID: 20102294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of St John's wort (hypericum perforatum) on cytochrome p450 1a2 activity in perfused rat liver.
    Dostalek M; Pistovcakova J; Jurica J; Sulcova A; Tomandl J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2011 Sep; 155(3):253-7. PubMed ID: 22286810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug interactions with St John's wort : mechanisms and clinical implications.
    Mannel M
    Drug Saf; 2004; 27(11):773-97. PubMed ID: 15350151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.